DexCom, Inc., which specializes in real-time continuous glucose monitoring for people with diabetes, has announced that the Dexcom G7 Continuous Glucose Monitoring (CGM) System now connects directly to Apple Watch in the U.S.
Jake Leach, executive vice president and chief operating officer at Dexcom, says Dexcom G7 is the first and only CGM available with Direct to Apple Watch, offering users the freedom and convenience of real-time glucose readings on their wrist even when their iPhone isn’t with them.
Using its own dedicated Bluetooth connection, Dexcom G7 sends glucose information and personalized alerts right to a user’s Apple Watch. Leach says Dexcom G7 is the only CGM system that can display glucose on multiple devices simultaneously and independently, including on a smartphone, smart watch, receiver or connected automated insulin delivery system.
In addition to the benefits of using Direct to Apple Watch with Dexcom G7, people with diabetes can track other key health metrics that can impact glucose levels using Apple’s Activity, Cycle Tracking, Sleep, and other health features on Apple Watch, iPhone and iPad. All of this data is stored securely in the Health app, where it can be viewed alongside Dexcom G7 data users choose to store in the Health app so all of their diabetes health information is accessible in one place.
Direct to Apple Watch is now available to Dexcom G7 users in the U.S., United Kingdom and Ireland, with additional markets launching later this month. To use Direct to Apple Watch, users must have the Dexcom G7 app version 2.1, Apple Watch Series 6 or later running watchOS 10 or later, and an iPhone running iOS 17 or later. To learn more about Direct to Apple Watch and see a list of compatible devices, visit www.Dexcom.com/G7.
